Skip to main content

Triamterene and Hydrochlorothiazide

NDC 70518-1662 · REMEDYREPACK INC.

Generic nameTriamterene and Hydrochlorothiazide
Dosage formTABLET
RouteORAL
Active ingredient(s)TRIAMTERENE, HYDROCHLOROTHIAZIDE
Strength25; 37.5 mg/1; mg/1
Pharmacologic classDecreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]
Marketing categoryANDA

Packages

70518-1662-0 — 30 TABLET in 1 BLISTER PACK (70518-1662-0)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

70377-139 — Triamterene, 70436-014 — olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide, 70436-015 — olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide, 70436-016 — olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide, 70436-017 — olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide, 70436-018 — olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide, 70518-0174 — Lisinopril and Hydrochlorothiazide, 70518-0196 — Lisinopril and Hydrochlorothiazide, 70518-0382 — Lisinopril and Hydrochlorothiazide, 70518-1550 — Irbesartan and Hydrochlorothiazide, 70518-2269 — Olmesartan Medoxomil and Hydrochlorothiazide, 70518-2550 — Hydrochlorothiazide, 70518-2737 — Losartan Potassium and Hydrochlorothiazide, 70518-3398 — losartan potassium and hydrochlorothiazide, 70518-3404 — losartan potassium and hydrochlorothiazide, 70518-3420 — losartan potassium and hydrochlorothiazide, 70518-3505 — Lisinopril and Hydrochlorothiazide Tablets, 70518-3749 — Hydrochlorothiazide, 70518-3780 — hydrochlorothiazide, 70518-4113 — Hydrochlorothiazide, +863 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels